16 January 2018 1 Min Read
Adcock Ingram climbs after positive HEPS forecast
Shares in the pharmaceutical manufacturer benefited after it said HEPS for the six months to end-December will be at least 27% higher than the previous period
Subscribe to our website to read this article and support quality journalism.
If you’ve already subscribed, simply sign in.
Subscribe Sign In